Treatment of Combined Autoimmune Neutropenia and Immune Thrombocytopenia with Methotrexate

In-situ formation of niobium oxide – niobium carbide – reduced graphene oxide ternary nanocomposite as an electrochemical sensor for sensitive detection of anticancer drug methotrexate

Engineering the nanostructure of an electrocatalyst is crucial in developing a high-performance electrochemical sensor. This work exhibits the hydrothermal followed by annealing synthesis of niobium oxide/niobium carbide/reduced graphene oxide (NbO/NbC/rGO) ternary nanocomposite. The oval-shaped NbO/NbC nanoparticles cover the surface of rGO evenly, and the rGO nanosheets are interlinked to produce a micro-flower-like architecture. The NbO/NbC/rGO nanocomposite-modified electrode is presented here for the first time for the rapid and sensitive electrochemical detection of the anticancer drug methotrexate (MTX). Down-sized NbO/NbC nanoparticles and rGO's high surface area provide many active sites with a rapid electron transfer rate, making them ideal for MTX detection. In comparison to previously reported MTX sensors, the developed drug sensor exhibits a lower oxidation potential and a higher peak current responsiveness. The constructed sensors worked analytically well under optimal conditions, as shown by a low detection limit of 1.6 nM, a broad linear range of 0.1-850 µM, and significant recovery findings (∼98 %, (n = 3)) in real samples analysis. Thus, NbO/NbC/rGO nanocomposite material for high-performance electrochemical applications seems promising.